OraSure Technologies Inc (OSUR) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the OSUR SEC filings page.
OraSure Technologies Inc (OSUR) reported $112.4M in revenue over the twelve months to Jun 30, 2026, down 18.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The business’s recent revenue contraction has exposed fixed-cost pressure despite low leverage and ample reported liquidity.
Revenue contraction from$405M in FY2023 to$115M in FY2025 shrank the base over which the company spreads its costs. Gross margin remained about41.9% while operating margin reached-62.6% , pointing to overhead and development spending—not production cost—as the main earnings pressure.
In FY2023, net income of
In FY2025, R&D spending consumed
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of OraSure Technologies Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
OraSure Technologies Inc held $199.3M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $49.0M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and OraSure Technologies Inc scores 67/100 among other emerging companies.
OraSure Technologies Inc had 69M shares outstanding at the end of fiscal year 2025, against 75M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and OraSure Technologies Inc scores 77/100 among other emerging companies.
OraSure Technologies Inc spent $42.5M on research and development in fiscal year 2025, which was 22.7% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and OraSure Technologies Inc scores 55/100 among other emerging companies.
OraSure Technologies Inc reported revenue of $115.0M in fiscal year 2025, against $185.8M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and OraSure Technologies Inc scores 6/100 among other emerging companies.
Not available for OraSure Technologies Inc, and counted as zero in the overall score.
OraSure Technologies Inc's cash, cash equivalents and investments came to $199.3M at the end of fiscal year 2025, against $62.3M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and OraSure Technologies Inc scores 83/100 among other emerging companies.
OraSure Technologies Inc scores 2.35, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($269.0M) relative to total liabilities ($62.3M). This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
OraSure Technologies Inc passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
OraSure Technologies Inc reported a net loss of $68.7M while operations used $49.0M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
OraSure Technologies Inc generated $30.6M in revenue in Q2 2026. This represents a decrease of 1.9% from the same quarter a year earlier. Against the prior quarter it is up 9.7%.
OraSure Technologies Inc's EBITDA was $7.8M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 150.4% from the same quarter a year earlier. Against the prior quarter it is up 137.3%.
OraSure Technologies Inc reported $6.2M in net income in Q2 2026. This represents an increase of 131.7% from the same quarter a year earlier. Against the prior quarter it is up 127.9%.
OraSure Technologies Inc earned $0.09 per diluted share (EPS) in Q2 2026. This represents an increase of 134.6% from the same quarter a year earlier. Against the prior quarter it is up 128.1%.
Cash & Balance Sheet
OraSure Technologies Inc recorded an outflow of $12.3M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 1.6% from the same quarter a year earlier. Against the prior quarter it is up 16.6%.
OraSure Technologies Inc held $160.6M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Margins & Returns
OraSure Technologies Inc's gross margin was 43.5% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 1.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.2 percentage points.
OraSure Technologies Inc's operating margin was 17.8% in Q2 2026, reflecting core business profitability. This is up 75.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 101.1 percentage points.
OraSure Technologies Inc's net profit margin was 20.4% in Q2 2026, showing the share of revenue converted to profit. This is up 83.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 100.5 percentage points.
OraSure Technologies Inc's ROE was 2.0% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 7.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 9.1 percentage points.
Capital Allocation
OraSure Technologies Inc invested $9.4M in research and development in Q2 2026. This represents a decrease of 17.2% from the same quarter a year earlier. Against the prior quarter it is down 30.9%.
OraSure Technologies Inc spent $2.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 60.0% from the same quarter a year earlier. Against the prior quarter it is down 60.0%.
OraSure Technologies Inc invested $2.4M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 25.4% from the same quarter a year earlier. Against the prior quarter it is up 165.9%.
OSUR Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $30.6M-1.9% | $27.9M-6.7% | $26.8M-28.5% | $27.1M-32.1% | $31.2M-42.5% | $29.9M-44.7% | $37.4M-50.7% | $39.9M-55.2% |
| Cost of Revenue | $17.3M-4.2% | $16.1M-8.6% | $15.8M-33.9% | $15.3M-33.0% | $18.1M-39.0% | $17.6M-41.4% | $23.9M-41.4% | $22.8M-49.1% |
| Gross Profit | $13.3M+1.2% | $11.8M-4.0% | $11.0M-19.2% | $11.8M-31.0% | $13.2M-46.7% | $12.3M-48.9% | $13.6M-61.4% | $17.1M-61.5% |
| R&D Expenses | $9.4M-17.2% | $13.7M+42.2% | $11.4M+87.6% | $10.1M+79.7% | $11.4M+72.8% | $9.6M+24.1% | $6.1M-12.9% | $5.6M-34.0% |
| SG&A Expenses | $14.4M+13.8% | $14.6M+3.2% | $9.8M-23.9% | $11.1M+12.7% | $12.7M+7.0% | $14.1M+21.2% | $12.9M-7.9% | $9.8M-2.2% |
| Operating Income | $5.4M+130.2% | -$23.3M-31.1% | -$20.1M-61.9% | -$16.1M-168.2% | -$18.0M-557.9% | -$17.8M-150.2% | -$12.4M-418.6% | -$6.0M-155.1% |
| EBITDA | $7.8M+150.4% | -$20.9M-40.1% | -$17.7M-78.3% | -$13.6M-362.1% | -$15.5M-11467.2% | -$14.9M-242.1% | -$9.9M-233.0% | -$3.0M-120.7% |
| Income Tax | $55K-97.3% | -$432K+5.3% | $210K-72.3% | $47K-93.1% | $2.0M+424.9% | -$456K-2433.3% | $758K+17.2% | $678K-71.1% |
| Net Income | $6.2M+131.7% | -$22.4M-39.5% | -$19.3M-78.7% | -$13.7M-204.2% | -$19.7M-3102.1% | -$16.0M-347.5% | -$10.8M-153.8% | -$4.5M-140.4% |
| EPS (Basic) | $0.09+134.6% | -$0.32-52.4% | -$0.27-92.9% | -$0.19-216.7% | -$0.26-2500.0% | -$0.21-320.0% | -$0.14-151.9% | -$0.06-140.0% |
| EPS (Diluted) | $0.09+134.6% | -$0.32-52.4% | -$0.27-92.9% | -$0.19-216.7% | -$0.26-2500.0% | -$0.21-320.0% | -$0.14-151.9% | -$0.06-140.0% |
| Diluted Shares (Avg) | 70M-5.9% | 70M-6.9% | N/A | 73M-2.1% | 75M+0.5% | 75M+1.2% | N/A | 75M+0.3% |
Not reported in any period shown, so not listed: Interest Expense.
OSUR Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $360.6M-19.0% | $379.2M-17.1% | $403.2M-15.9% | $423.1M-8.8% | $445.0M-4.6% | $457.6M-2.1% | $479.7M-0.7% | $464.1M+1.2% |
| Current Assets | $222.9M-26.0% | $240.8M-23.3% | $261.9M-21.4% | $283.0M-19.2% | $301.4M-14.1% | $313.8M-10.0% | $333.2M-13.8% | $350.2M-1.8% |
| Cash & Equivalents | $160.6M-31.5% | $177.0M-28.5% | $199.3M-25.6% | $216.5M-22.3% | $234.6M-9.2% | $247.6M+0.2% | $267.8M-7.8% | $278.6M+28.1% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0-100.0% | $0-100.0% | $0 | $0-100.0% |
| Inventory | $30.1M-9.9% | $30.3M-15.1% | $31.1M-9.2% | $33.4M-14.1% | $33.4M-12.8% | $35.7M-17.4% | $34.2M-28.2% | $38.9M-34.4% |
| Accounts Receivable | $25.6M-1.2% | $24.8M+15.3% | $22.2M-6.8% | $24.3M-9.8% | $25.9M-32.0% | $21.5M-36.8% | $23.8M-40.7% | $27.0M-49.5% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $42.7M+2.3% | $43.0M+6.4% | $43.4M+7.5% | $41.3M+17.1% | $41.7M+19.4% | $40.4M+15.0% | $40.3M+13.0% | $35.3M+0.7% |
| Total Liabilities | $42.8M-33.5% | $65.8M+7.4% | $62.3M-10.1% | $61.1M+58.7% | $64.3M+58.8% | $61.3M+48.5% | $69.3M+32.9% | $38.5M-28.1% |
| Current Liabilities | $25.1M-40.7% | $44.1M+73.4% | $39.8M+18.9% | $40.2M+44.9% | $42.4M+46.8% | $25.4M-12.7% | $33.5M-15.3% | $27.8M-32.1% |
| Non-Current Liabilities | $17.7M-19.6% | $21.8M-39.4% | $22.5M-37.1% | $20.9M+94.4% | $22.0M+88.5% | $35.9M+194.2% | $35.8M+183.6% | $10.7M-14.8% |
| Total Equity | $317.8M-16.5% | $313.3M-20.9% | $340.8M-16.9% | $362.0M-14.9% | $380.7M-10.6% | $396.3M-7.0% | $410.3M-4.7% | $425.6M+5.1% |
| Retained Earnings | -$188.3M-35.3% | -$194.5M-62.8% | -$172.2M-66.5% | -$152.9M-65.0% | -$139.2M-57.9% | -$119.5M-36.5% | -$103.4M-23.2% | -$92.6M+10.9% |
Not reported in any period shown, so not listed: Long-Term Debt.
OSUR Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$9.9M+3.0% | -$13.9M+29.6% | -$9.0M-8353.2% | -$10.1M-179.4% | -$10.2M-230.3% | -$19.7M-392.8% | $109K-99.7% | $12.7M-65.7% |
| Depreciation & Amortization | $2.4M-6.1% | $2.3M-16.6% | $2.4M-3.6% | $2.5M-19.5% | $2.5M-3.1% | $2.8M+3.0% | $2.5M-30.1% | $3.0M-9.3% |
| Stock-Based Compensation | $2.3M-27.7% | $2.8M+3.0% | N/A | $2.8M-1.8% | $3.2M-4.7% | $2.7M-9.5% | N/A | $2.9M |
| Capital Expenditures | $2.4M+25.4% | $913K+117.4% | $922K+102.2% | $919K+533.8% | $1.9M+19.7% | $420K-73.4% | $456K-64.5% | $145K-91.1% |
| Free Cash Flow | -$12.3M-1.6% | -$14.8M+26.5% | -$9.9M-2758.2% | -$11.0M-187.7% | -$12.2M-295.3% | -$20.2M-490.6% | -$347K-100.9% | $12.5M-64.5% |
| Investing Cash Flow | -$2.4M-24.4% | -$913K-346.8% | -$4.4M+19.5% | -$821K-111.2% | -$1.9M-134.2% | $370K+100.8% | -$5.5M-118.0% | $7.3M+385.2% |
| Financing Cash Flow | -$2.2M+61.2% | -$6.3M-559.2% | -$5.1M-4507.2% | -$5.1M-599.6% | -$5.8M-184.1% | -$953K+26.6% | -$111K+68.7% | -$726K-3.0% |
| Share Buybacks | $2.0M-60.0% | $5.0M | $5.0M | $5.0M | $5.0M+242.0% | $0-100.0% | $0-100.0% | $0-100.0% |
Not reported in any period shown, so not listed: Dividends Paid.
OSUR Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.5%+1.3pp | 42.3%+1.2pp | 41.0%+4.7pp | 43.5%+0.7pp | 42.1%-3.3pp | 41.1%-3.4pp | 36.2%-10.1pp | 42.8%-6.9pp |
| Operating Margin | 17.8%+75.5pp | -83.3%-24.0pp | -75.1%-41.9pp | -59.4%-44.4pp | -57.7%-52.7pp | -59.3%-46.2pp | -33.2%-38.3pp | -15.0%-27.2pp |
| Net Margin | 20.4%+83.4pp | -80.1%-26.5pp | -72.1%-43.2pp | -50.6%-39.3pp | -63.0%-61.9pp | -53.6%-47.0pp | -28.8%-55.3pp | -11.3%-23.8pp |
| Return on Equity | 2.0%+7.1pp | -7.1%-3.1pp | -5.7%-3.0pp | -3.8%-2.7pp | -5.2%-5.0pp | -4.0%-3.2pp | -2.6%-7.3pp | -1.1%-3.8pp |
| Return on Assets | 1.7%+6.2pp | -5.9%-2.4pp | -4.8%-2.5pp | -3.2%-2.3pp | -4.4%-4.3pp | -3.5%-2.7pp | -2.3%-6.4pp | -1.0%-3.4pp |
| Current Ratio | 8.88+1.8x | 5.46-6.9x | 6.58-3.4x | 7.03-5.6x | 7.12-5.0x | 12.34+0.4x | 9.95+0.2x | 12.60+3.9x |
| Debt-to-Equity | 0.130.0x | 0.21+0.1x | 0.180.0x | 0.17+0.1x | 0.17+0.1x | 0.15+0.1x | 0.170.0x | 0.090.0x |
| Asset Turnover | 0.090.0x | 0.070.0x | 0.070.0x | 0.060.0x | 0.070.0x | 0.07-0.1x | 0.08-0.1x | 0.09-0.1x |
| FCF Margin | -40.3%-1.4pp | -53.0%+14.3pp | -37.1%-36.1pp | -40.6%-72.0pp | -38.9%-50.4pp | -67.3%-76.9pp | -0.9%-53.8pp | 31.4%-8.2pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| OraSure Technologies Inc OSUR | FY2025 | $115.0M | -$68.7M | -59.8% | $269.0M | 48/100 |
| Sharps Technology Inc. STSS | FY2025 | $204K | -$282.5M | N/A | $77.9M | — |
| Stereotaxis, Inc. STXS | FY2025 | $32.4M | -$21.6M | -66.8% | $111.2M | 43/100 |
| InfuSystem Holdings, Inc. INFU | FY2025 | $143.4M | $6.6M | 4.6% | $270.1M | 59/100 |
| Utah Medical Products Inc UTMD | FY2025 | $38.5M | $11.3M | 29.3% | $236.6M | 78/100 |
Where OraSure Technologies Inc Ranks
Frequently Asked Questions
What is OraSure Technologies Inc's annual revenue?
OraSure Technologies Inc (OSUR) reported $115.0M in total revenue for fiscal year 2025. This represents a -38.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is OraSure Technologies Inc's revenue growing?
OraSure Technologies Inc (OSUR) revenue declined by 38.1% year-over-year, from $185.8M to $115.0M in fiscal year 2025.
Is OraSure Technologies Inc profitable?
No, OraSure Technologies Inc (OSUR) reported a net income of -$68.7M in fiscal year 2025, with a net profit margin of -59.8%.
What is OraSure Technologies Inc's EBITDA?
OraSure Technologies Inc (OSUR) had EBITDA of -$61.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is OraSure Technologies Inc's gross margin?
OraSure Technologies Inc (OSUR) had a gross margin of 41.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is OraSure Technologies Inc's operating margin?
OraSure Technologies Inc (OSUR) had an operating margin of -62.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is OraSure Technologies Inc's net profit margin?
OraSure Technologies Inc (OSUR) had a net profit margin of -59.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is OraSure Technologies Inc's return on equity (ROE)?
OraSure Technologies Inc (OSUR) has a return on equity of -20.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is OraSure Technologies Inc's free cash flow?
OraSure Technologies Inc (OSUR) recorded an outflow of $53.2M in free cash flow during fiscal year 2025. This represents a -325.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is OraSure Technologies Inc's operating cash flow?
OraSure Technologies Inc (OSUR) recorded an outflow of $49.0M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are OraSure Technologies Inc's total assets?
OraSure Technologies Inc (OSUR) had $403.2M in total assets as of fiscal year 2025, including both current and long-term assets.
What are OraSure Technologies Inc's capital expenditures?
OraSure Technologies Inc (OSUR) invested $4.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does OraSure Technologies Inc spend on research and development?
OraSure Technologies Inc (OSUR) invested $42.5M in research and development during fiscal year 2025.
What is OraSure Technologies Inc's current ratio?
OraSure Technologies Inc (OSUR) had a current ratio of 6.58 as of fiscal year 2025, which is generally considered healthy.
What is OraSure Technologies Inc's debt-to-equity ratio?
OraSure Technologies Inc (OSUR) had a debt-to-equity ratio of 0.18 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is OraSure Technologies Inc's return on assets (ROA)?
OraSure Technologies Inc (OSUR) had a return on assets of -17.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is OraSure Technologies Inc's P/E ratio?
OraSure Technologies Inc (OSUR) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $269.0M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is OraSure Technologies Inc's price-to-sales ratio?
OraSure Technologies Inc (OSUR) trades at 2.4x sales, its market capitalization divided by revenue of $112.4M revenue, trailing 12 months to June 30, 2026. The market capitalization is $269.0M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does OraSure Technologies Inc's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, OraSure Technologies Inc (OSUR) held $199.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $49.0M over that year. Dividing the one by the other, the reported balance equals about 49 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is OraSure Technologies Inc's Altman Z-Score?
OraSure Technologies Inc (OSUR) has an Altman Z-Score of 2.35, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is OraSure Technologies Inc's Piotroski F-Score?
OraSure Technologies Inc (OSUR) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are OraSure Technologies Inc's earnings high quality?
OraSure Technologies Inc (OSUR) reported a net loss of $68.7M while operations used $49.0M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is OraSure Technologies Inc?
OraSure Technologies Inc (OSUR) scores 48 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.